News

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
By Andrew Silver SHANGHAI (Reuters) -Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its ...
You've heard about the likes of Ozempic, Wegovy and Mounjaro, jabs which a growing number of people are taking in an attempt ...
This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...
From 1 July, the weight-loss drug Wegovy will become available from Belgian pharmacists on prescription. This means Wegovy is ...
There's expectations weight-loss drug Wegovy will eventually be funded publicly, according to experts. It's become available ...
The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...
Professor of Public Health Grant Scofield joins Emile Donovan to discuss the effectiveness of Wegovy and Ozempic, and whether ...
The MHRA has revealed it's received more than 560 reports of acute pancreatitis in patients taking GLP-1 injections since ...